In situ detection of cyclic AMP-phosphodiesterase activity in the heart of Lewis and Sprague-Dawley rats: the effect of restraint stress or amphetamine application.

Cyclic AMP plays an important role in heart functions under normal as well as pathological conditions. Since phosphodiesterase (PDE), responsible for the hydrolysis of cAMP, is equally important as synthesizing adenylyl cyclase, we decided to determine its activity by cytochemical procedure after exposure of rats to restraint stress or an acute dose of amphetamine. Sprague-Dawley (S-D) and Lewis (LE) rats, the latter known to have a deficient hypothalamo-pituitary-adrenal axis activity, were used in order to disclose the possible significance of rat strain on PDE activity. Animals were divided into 3 groups: controls, rats treated with an acute dose of amphetamine (8 mg/kg, i.p., for 60 min) and rats under restraint stress for 60 min. Control hearts of both strains revealed PDE activity on sarcolemma of cardiomyocytes and plasmalemma of endothelial cells of microvessels. In LE rats we observed an additional enzyme reaction in junctional sarcoplasmic reticulum. In addition, cardiomyocytes of LE rats revealed a higher PDE activity when compared to S-D rats. Restraint stress decreased PDE activity in cardiomyocytes of LE rats while amphetamine markedly inhibited enzyme activity in cardiomyocytes of S-D rats. Endothelial PDE was more resistant to stress. Our results indicate differences in PDE localization and variations in sensitivity of myocardial cAMP-PDE of LE and S-D rat strains to restraint stress and amphetamine application.

[1]  C. Lugnier,et al.  Cytochemical distribution of cyclic AMP-dependent 3′,5′-nucleotide phosphodiesterase in the rat myocardium , 1996, The Histochemical Journal.

[2]  W. K. Sonnenburg,et al.  The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases , 1993, Molecular and Cellular Biochemistry.

[3]  N. Tribulova,et al.  Modulation of cAMP level by tedisamil in guinea pig heart , 2000, Molecular and Cellular Biochemistry.

[4]  C. Lugnier,et al.  Species differences in localization of cardiac cAMP-phosphodiesterase activity: A cytochemical study , 1997, Molecular and Cellular Biochemistry.

[5]  V. Klenerova,et al.  Differences in response to activation of adenylyl cyclase by various stimulants in human myocardium , 1996, Molecular and Cellular Biochemistry.

[6]  C. Nicholson,et al.  Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  Z. Hliňák,et al.  Combined restraint and cold stress in rats: effects on memory processing in passive avoidance task and on plasma levels of ACTH and corticosterone , 2003, Behavioural Brain Research.

[8]  Z. Hliňák,et al.  Impaired passive avoidance acquisition in Sprague–Dawley and Lewis rats after restraint and cold stress , 2002, Behavioural Brain Research.

[9]  L. Koch,et al.  Myocardial function in rat genetic models of low and high aerobic running capacity. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  V. Klenerova,et al.  Differences in the behaviour of Sprague--Dawley and Lewis rats during repeated passive avoidance procedure: effect of amphetamine. , 2001, Pharmacological research.

[11]  T. Ravingerová,et al.  Activation of adenylate cyclase system in the preconditioned rat heart. , 2000, Physiological research.

[12]  J. Ps,et al.  Influence of different types of stress on selected cardiovascular parameters in rats. , 1999 .

[13]  V. Klenerova,et al.  Effects of immobilization stress combined with water immersion and chronic amphetamine treatment on the adenylyl cyclase activity in rat neurohypophysis. , 1999, Physiological Research.

[14]  H. Nagaraja,et al.  Influence of different types of stress on selected cardiovascular parameters in rats. , 1999, Indian journal of physiology and pharmacology.

[15]  L. Koch,et al.  Spectrum of aerobic endurance running performance in eleven inbred strains of rats. , 1998, Journal of applied physiology.

[16]  V. Klenerova,et al.  Different activity of adenylyl cyclase in prefrontal cortex in three rat strains. The effect of amphetamine. , 1998, Folia biologica.

[17]  R. Mazzeo,et al.  Alterations in myocardial signal transduction due to aging and chronic dynamic exercise. , 1998, Journal of applied physiology.

[18]  A. Aileru,et al.  Arrhythmogenic and antiarrhythmic actions of substances of abuse: effects on triggered activity. , 1997, Journal of electrocardiology.

[19]  J E Saffitz,et al.  Functional and structural assessment of intercellular communication. Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes. , 1996, Circulation research.

[20]  L. Szekeres On the mechanism and possible therapeutic application of delayed cardiac adaptation to stress. , 1996, The Canadian journal of cardiology.

[21]  R Fischmeister,et al.  cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Lugnier,et al.  Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway , 1994, British journal of pharmacology.

[23]  J. Beavo,et al.  Multiple cyclic nucleotide phosphodiesterases. , 1994, Molecular pharmacology.

[24]  É. Rousseau,et al.  Characterization of indolidan- and rolipram-sensitive cyclic nucleotide phosphodiesterases in canine and human cardiac microsomal fractions. , 1993, The Journal of pharmacology and experimental therapeutics.

[25]  M. Conti,et al.  Hormonal regulation of cyclic nucleotide phosphodiesterases. , 1991, Endocrine reviews.

[26]  I. Petkova,et al.  Stress-induced changes in the cyclic nucleotide concentrations and phosphorylase activity in the myocardium. , 1991, Acta physiologica et pharmacologica Bulgarica.

[27]  M. Shahid,et al.  Species‐dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardium , 1990, The Journal of pharmacy and pharmacology.

[28]  J. Beavo,et al.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. , 1990, Trends in pharmacological sciences.

[29]  N. Tribulova,et al.  [Changes in adenylate cyclase activity in the early phases of ischemia in cardiac myocytes]. , 1988, Bratislava Medical Journal.

[30]  N. V. Karsanov,et al.  Subcellular bases of cardiac disturbance in experimental informational neurosis. , 1987, International Journal of Psychophysiology.

[31]  S. Sparber,et al.  Amphetamine cumulation and tolerance development: Concurrent and opposing phenomena , 1984, Pharmacology Biochemistry and Behavior.

[32]  M. Ui,et al.  Plasma cyclic nucleotide responses to psychological stress in normal and neurotic subjects. , 1983, The Journal of clinical endocrinology and metabolism.

[33]  S. I. Kashtanov,et al.  [Acute emotional stress and cyclic nucleotide content of the heart and blood plasma]. , 1983, Biulleten' eksperimental'noi biologii i meditsiny.

[34]  A. Katz Regulation of Cardiac Contractile Activity by Cyclic Nucleotides , 1982 .

[35]  S. Geller,et al.  Cytochemical demonstration of adenylate cyclase in cardiac muscle: effect of dimethyl sulfoxide. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  E. Krause,et al.  Myocardial cyclic nucleotide levels following coronary artery ligation. , 1978, Advances in cardiology.

[37]  M. Makman,et al.  8 – CYCLIC NUCLEOTIDES , 1977 .

[38]  L. Simpson Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation. , 1975, The Journal of pharmacology and experimental therapeutics.

[39]  A. Katz,et al.  Adenylate cyclase: its probable localization in sarcoplasmic reticulum as well as sarcolemma of the canine heart. , 1974, Journal of molecular and cellular cardiology.